How machine vision is disrupting and changing life science industries
If you work in the life sciences, you’re well aware of the rapid growth and change that is affecting much of the industry. Many machine vision trends are contributing to this somewhat tumultuous, but exciting time.
Machine vision helps us see and understand
Researchers have been able to create technology that can see life on the tiniest scales imaginable. And not only can we now see the very small, but this technology also helps us to interpret what we are seeing. With the addition of 5G networks, doctors and researchers will be able to use machine vision to see what’s going on with a patient from around the world in real-time.
Machine vision helps doctors diagnose disease, view scans faster, and sort medical images efficiently. Doctors can use machine vision to access detailed information during surgery. Even today, much of what we know about life involves a lot of guessing. But thanks to current machine vision trends, the answers to life’s mysteries are being revealed.
Machine vision trends include artificial intelligence
Although many applications of machine vision simply augment human capabilities, artificial intelligence (AI) is changing the Life Sciences. When AI is paired with machine vision, mundane tasks can be automated. Artificial intelligence is analyzing a plethora of data sets collected from health records, clinical trials, and genetic profiles.
The world population is growing and aging fast. Fortunately, machine vision is growing rapidly too. The amount of medical data captured and stored is increasing quickly. Big Data can be analyzed by AI and machine learning to better understand Life Sciences. Probabilities regarding disease and diagnoses help doctors make educated guesses about pathology.
But can AI really make an impact? Many facilities have found that the adoption of AI technology is cutting healthcare costs and improving patient outcomes. Others say that artificial intelligence makes their doctors faster and more accurate than ever before. Venture capital and private equity firms are investing in AI, machine vision and life science companies. AI tech companies offer promise to discover treatments and drugs faster than conventional means.
This article originally appeared in Vision Online. AIA is a part of the Association for Advancing Automation (A3), a CFE Media content partner.